Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816].

Authors:
Shahin Akhondzadeh
Shahin Akhondzadeh
Tehran University of Medical Sciences
Iran
Khosro Afkham
Khosro Afkham
Tehran University of Medical Sciences
Iran

BMC Complement Altern Med 2004 Sep 2;4:12. Epub 2004 Sep 2.

Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Street, Tehran 13185, Iran.

Background: The morbidity and mortality associated with depression are considerable and continue to increase. Depression currently ranks fourth among the major causes of disability worldwide, after lower respiratory infections, prenatal conditions, and HIV/AIDS. Crocus sativus L. is used to treat depression. Many medicinal plants textbooks refer to this indication whereas there is no evidence-based document. Our objective was to compare the efficacy of stigmas of Crocus sativus (saffron) with imipramine in the treatment of mild to moderate depression in a 6-week pilot double-blind randomized trial.

Methods: Thirty adult outpatients who met the Diagnostic and Statistical Manual of Mental Disorders, 4th edition for major depression based on the structured clinical interview for DSM IV participated in the trial. Patients have a baseline Hamilton Rating Scale for Depression score of at least 18. In this double-blind, single-center trial, patients were randomly assigned to receive capsule of saffron 30 mg/day (TDS) (Group 1) and capsule of imipramine 100 mg/day (TDS) (Group 2) for a 6-week study.

Results: Saffron at this dose was found to be effective similar to imipramine in the treatment of mild to moderate depression (F = 2.91, d.f. = 1, P = 0.09). In the imipramine group anticholinergic effects such as dry mouth and also sedation were observed more often that was predictable.

Conclusion: The main overall finding from this study is that saffron may be of therapeutic benefit in the treatment of mild to moderate depression. To the best of our knowledge this is the first clinical trial that supports this indication for saffron. A large-scale trial with placebo control is warranted.

Download full-text PDF

Source
http://dx.doi.org/10.1186/1472-6882-4-12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC517724PMC

Still can't find the full text of the article?

We can help you send a request to the authors directly.
September 2004
47 Reads

Article Mentions


Provided by Crossref Event Data
wikipedia
Wikipedia: Crocina
January 7, 2018, 2:36 pm EST
wikipedia
Wikipedia: Crocin
September 27, 2017, 5:44 pm EST
wikipedia
Wikipedia: Safranal
May 6, 2017, 6:58 pm EST
cambia-lens
Cambia-lens:
September 23, 2009, 8:00 pm EST

Publication Analysis

Top Keywords

moderate depression
16
mild moderate
16
treatment mild
16
crocus sativus
12
imipramine treatment
12
depression
9
pilot double-blind
8
double-blind randomized
8
trial patients
8
mg/day tds
8
tds group
8
trial
5
saffron
5
imipramine
5
adult outpatients
4
capsule saffron
4
sedation observed
4
thirty adult
4
observed predictableconclusion
4
trialmethods thirty
4

References

(Supplied by CrossRef)
Article in Int J Clin Psychopharm
L Judd et al.
Int J Clin Psychopharm 1995
Article in Mayo Clin Proc
E Richelson et al.
Mayo Clin Proc 1994
Article in J Affec Dis
K Demyttenaere et al.
J Affec Dis 1997
Article in Br J Psychiatry
JM Donoghue et al.
Br J Psychiatry 1996
Article in Prim Care Psychiatry
TM MacDonald et al.
Prim Care Psychiatry 1997
Article in Phytomedicine
E Ernst et al.
Phytomedicine 1995
Article in BMJ
PAGM De Smet et al.
BMJ 1996
Article in Phtother Res
JL Rios et al.
Phtother Res 1996
Article in Iranian J Basic Med Sci
G Karimi et al.
Iranian J Basic Med Sci 2001
Article in BMC Pharmacol
H Hosseinzadeh et al.
BMC Pharmacol 2002
Article in Exp Biol Med
FI Addullaev et al.
Exp Biol Med 2002

Similar Publications